AU2003253440A1 - Method of diagnosing ovarian endometriosis - Google Patents

Method of diagnosing ovarian endometriosis

Info

Publication number
AU2003253440A1
AU2003253440A1 AU2003253440A AU2003253440A AU2003253440A1 AU 2003253440 A1 AU2003253440 A1 AU 2003253440A1 AU 2003253440 A AU2003253440 A AU 2003253440A AU 2003253440 A AU2003253440 A AU 2003253440A AU 2003253440 A1 AU2003253440 A1 AU 2003253440A1
Authority
AU
Australia
Prior art keywords
ovarian endometriosis
methods
diagnosing ovarian
endometriosis
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003253440A
Other languages
English (en)
Other versions
AU2003253440A8 (en
Inventor
Toyomasa Katagiri
Yusuke Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
The University of Tokyo
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of AU2003253440A8 publication Critical patent/AU2003253440A8/xx
Publication of AU2003253440A1 publication Critical patent/AU2003253440A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003253440A 2002-08-30 2003-08-12 Method of diagnosing ovarian endometriosis Abandoned AU2003253440A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40736502P 2002-08-30 2002-08-30
US60/407,365 2002-08-30
US45092003P 2003-02-28 2003-02-28
US60/450,920 2003-02-28
PCT/JP2003/010257 WO2004024952A1 (en) 2002-08-30 2003-08-12 Method of diagnosing ovarian endometriosis

Publications (2)

Publication Number Publication Date
AU2003253440A8 AU2003253440A8 (en) 2004-04-30
AU2003253440A1 true AU2003253440A1 (en) 2004-04-30

Family

ID=31997699

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003253440A Abandoned AU2003253440A1 (en) 2002-08-30 2003-08-12 Method of diagnosing ovarian endometriosis

Country Status (7)

Country Link
EP (1) EP1537243B1 (cg-RX-API-DMAC7.html)
JP (2) JP4401295B2 (cg-RX-API-DMAC7.html)
AT (1) ATE397098T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003253440A1 (cg-RX-API-DMAC7.html)
CA (1) CA2497132A1 (cg-RX-API-DMAC7.html)
DE (1) DE60321356D1 (cg-RX-API-DMAC7.html)
WO (1) WO2004024952A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005029089A2 (en) * 2003-09-24 2005-03-31 Oncotherapy Science, Inc. Method of diagnosing ovarian endometriosis using tfpi-2 protein
MX2007009562A (es) * 2005-02-18 2008-03-11 Gov Health & Human Serv Identificacion de marcadores de diagnostico moleculares para endometriosis en linfocitos sanguineos.
US11287425B2 (en) 2009-04-22 2022-03-29 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
EP2065707A1 (en) 2007-11-28 2009-06-03 Laboratorios S.A.L.V.A.T., S.A. Detection of endometrial secretion markers for assesment of endometriosis
CA2729403A1 (en) 2008-06-30 2010-01-07 Oncotherapy Science, Inc. Anti-cdh3 antibodies labeled with radioisotope label and uses thereof
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
JP5526378B2 (ja) * 2009-03-05 2014-06-18 国立大学法人山口大学 子宮頸癌の検出方法
CN102781964B (zh) 2009-12-28 2015-11-25 肿瘤疗法科学股份有限公司 抗cdh3抗体及其用途
JP5224308B2 (ja) * 2010-02-22 2013-07-03 公立大学法人横浜市立大学 卵巣明細胞腺癌に特異的に発現しているタンパク質とその応用
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
WO2016011377A1 (en) * 2014-07-17 2016-01-21 Celmatix Inc. Methods and systems for assessing infertility and related pathologies
JP6535357B2 (ja) * 2017-02-06 2019-06-26 国立研究開発法人農業・食品産業技術総合研究機構 非アルコール性脂肪肝治療用組成物、非アルコール性脂肪肝の治療剤の候補物質のスクリーニング方法及びｄｎａチップ
KR102897619B1 (ko) * 2018-04-20 2025-12-09 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 자궁내막증을 치료하기 위한 조성물 및 방법
CN110408695A (zh) * 2019-04-05 2019-11-05 辽宁省肿瘤医院 子宫内膜异位症恶变相关卵巢癌诊断或预后标志物及应用
JP7535270B2 (ja) * 2019-04-26 2024-08-16 中外製薬株式会社 子宮内膜症の診断方法、病態モニタリング方法及びキット
WO2021215531A1 (ja) * 2020-04-24 2021-10-28 花王株式会社 月経周期マーカー
WO2024223379A1 (en) * 2023-04-27 2024-10-31 Scailyte Ag Biomarkers for the diagnosis of diseases or disorders of the female reproductive tract
CN119769990B (zh) * 2024-12-26 2025-09-09 大连医科大学附属第二医院 子宫内膜异位症的检测系统和治疗剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0828003A3 (en) * 1996-09-06 2003-01-15 SmithKline Beecham plc Human serine protease
GB9806104D0 (en) * 1998-03-20 1998-05-20 Smithkline Beecham Biolog Novel compounds
DE69933661T3 (de) * 1998-04-15 2012-01-26 Merck Serono Biodevelopment Genomische sequenz des 5-lipoxygenase-aktivierenden proteins (flap), polymorphische marker und ihre anwendung in der diagnose von asthma
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
AU2001266787A1 (en) * 2000-06-07 2002-01-08 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
US6774223B2 (en) * 2000-06-28 2004-08-10 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating colon cancer
DE10048633A1 (de) * 2000-09-25 2002-04-18 Schering Ag Methode zur in vitro Diagnostik von Endometriose
EP1202065A1 (en) * 2000-10-25 2002-05-02 Aventis Pharma S.A. Net, a transcription factor of the TCF family, as regulator of angiogenic expression.

Also Published As

Publication number Publication date
EP1537243B1 (en) 2008-05-28
DE60321356D1 (de) 2008-07-10
ATE397098T1 (de) 2008-06-15
JP2005537027A (ja) 2005-12-08
CA2497132A1 (en) 2004-03-25
AU2003253440A8 (en) 2004-04-30
JP4401295B2 (ja) 2010-01-20
EP1537243A1 (en) 2005-06-08
WO2004024952A1 (en) 2004-03-25
JP4942052B2 (ja) 2012-05-30
JP2010029189A (ja) 2010-02-12

Similar Documents

Publication Publication Date Title
AU2003253440A8 (en) Method of diagnosing ovarian endometriosis
AU2003272414A1 (en) Method for detecting suspicious transactions
WO2003093960A9 (en) Security maturity assessment method
WO2004083816A3 (en) Loss of heterozygosity of the dna markers in the 12q22-23 region
WO2004031412A3 (en) Method for diagnosing pancreatic cancer
NO20014826L (no) Fremgangsmåte for lokalisering av foringsrörskjöter, samt apparat
WO2004060302A3 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
WO2000056937A3 (en) Solution-based methods and materials for sequence analysis by hybridization
AU2002341621A1 (en) Methods, reagents, kits and apparatus for protein function analysis
TW200600785A (en) Method for diagnosing non-small cell lung cancer
AU2003304434A1 (en) System, software and methods for biomarker identification
EP1700120A4 (en) MARKER FOR OPTICAL NEUROMYELITIS
EP2851856B8 (en) System, apparatus, program, and method for authentication
WO2004069184A3 (en) Methods for treating, preventing and detecting helicobacter infection
IL200120A0 (en) Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes
AU2003202770A1 (en) Method of, and apparatus for, determining position
WO2004016160A3 (en) Redox polymer nanoparticles
AU2003240934A1 (en) Method for determining oligonucleotide concentration
WO2004043232A3 (en) Methods for identifying risk of melanoma and treatments thereof
WO2004033666A3 (en) Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases
GB0126319D0 (en) Microfluidic serrs detection
WO2005031004A3 (de) Verfahren zum spezifischen schnellnachweis getränkeschädlicher mikroorganismen
AU2003275856A1 (en) Method for detecting halitosis
WO2005050889A3 (en) Method and apparatus for packet detection processing
WO2004031774A3 (en) Method for treating or preventing metastasis of colorectal cancers

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase